Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma

Journal of Proteomics

Volumn 75, Issue 6, 2012, Pages 1803-1815

  Katada, Koji ^a   Tomonaga, Takeshi ^b,c   Satoh, Mamoru ^c   Matsushita, Kazuyuki ^c   Tonoike, Yurie ^a   Kodera, Yoshio ^d   Hanazawa, Toyoyuki ^a   Nomura, Fumio ^c   Okamoto, Yoshitaka ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

2D DIGE; Head and neck cancer; Plectin; Prognostic marker

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARAFFIN; PLECTIN; SMALL INTERFERING RNA; TUMOR MARKER; UVOMORULIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEOPLASM INVASIVENESS; PLECTIN; PROGNOSIS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84857653875     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.018     Document Type: Article

References (50)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Gold K.A., Lee H.Y., Kim E.S. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009, 115:922-935.
3. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003, 260:502-508.
4. Yarbrough W.G., Slebos R.J., Liebler D. Proteomics: clinical applications for head and neck squamous cell carcinoma. Head Neck 2006, 28:549-558.
5. Srinivas P.R., Verma M., Zhao Y., Srivastava S. Proteomics for cancer biomarker discovery. Clin Chem 2002, 48:1160-1169.
6. Tomonaga T., Matsushita K., Yamaguchi S., Oh-Ishi M., Kodera Y., Maeda T., et al. Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin Cancer Res 2004, 10:2007-2014.
7. Nishimori T., Tomonaga T., Matsushita K., Oh-Ishi M., Kodera Y., Maeda T., et al. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 2006, 6:1011-1018.
8. Seimiya M., Tomonaga T., Matsushita K., Sunaga M., Oh-Ishi M., Kodera Y., et al. Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology 2008, 48:519-530.
9. Wu D., Matsushita K., Matsubara H., Nomura F., Tomonaga T. An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer. Int J Cancer 2011, 128:1018-1030.
10. Karp N.A., Kreil D.P., Lilley K.S. Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4:1421-1432.
11. Hu Y., Malone J.P., Fagan A.M., Townsend R.R., Holtzman D.M. Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol Cell Proteomics 2005, 4:2000-2009.
12. Mercurio A.M., Rabinovitz I., Shaw L.M. The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol 2001, 13:541-545.
13. Lipscomb E.A., Mercurio A.M. Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev 2005, 24:413-423.
14. Mercurio A.M., Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin Cancer Biol 2001, 11:129-141.
15. Osmanagic-Myers S., Gregor M., Walko G., Burgstaller G., Reipert S., Wiche G. Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol 2006, 174:557-568.
16. Janda E., Lehmann K., Killisch I., Jechlinger M., Herzig M., Downward J., et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002, 156:299-313.
17. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003, 253:269-285.
18. Whyte J., Bergin O., Bianchi A., McNally S., Martin F. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res 2009, 11:209.
19. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000, 148:779-790.
20. Hulit J., Suyama K., Chung S., Keren R., Agiostratidou G., Shan W., et al. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 2007, 67:3106-3116.
21. Kurokawa A., Nagata M., Kitamura N., Noman A.A., Ohnishi M., Ohyama T., et al. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma. Cancer 2008, 112:1272-1281.
22. Mattijssen V., Peters H.M., Schalkwijk L., Manni J.J., van 't Hof-Grootenboer B., de Mulder P.H., et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 1993, 55:580-585.
23. Bowie G.L., Caslin A.W., Roland N.J., Field J.K., Jones A.S., Kinsella A.R. Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci 1993, 18:196-201.
24. Takes R.P., Baatenburg De Jong R.J., Alles M.J., Meeuwis C.A., Marres H.A., Knegt P.P., et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002, 128:512-518.
25. Boczonadi V., McInroy L., Maatta A. Cytolinker cross-talk: periplakin N-terminus interacts with plectin to regulate keratin organisation and epithelial migration. Exp Cell Res 2007, 313:3579-3591.
26. Rezniczek G.A., de Pereda J.M., Reipert S., Wiche G. Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites. J Cell Biol 1998, 141:209-225.
27. Chao C., Lotz M.M., Clarke A.C., Mercurio A.M. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res 1996, 56:4811-4819.
28. Lu S., Simin K., Khan A., Mercurio A.M. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res 2008, 14:1050-1058.
29. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J Cell Sci 2004, 117:4619-4628.
30. Ding Y., Zhang L., Goodwin J.S., Wang Z., Liu B., Zhang J., et al. Plectin regulates the signaling and trafficking of the HIV-1 co-receptor CXCR4 and plays a role in HIV-1 infection. Exp Cell Res 2008, 314:590-602.
31. Kaifi J.T., Yekebas E.F., Schurr P., Obonyo D., Wachowiak R., Busch P., et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 2005, 97:1840-1847.
32. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
33. Yasumoto K., Koizumi K., Kawashima A., Saitoh Y., Arita Y., Shinohara K., et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 2006, 66:2181-2187.
34. Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000, 6:3530-3535.
35. Katayama A., Ogino T., Bandoh N., Nonaka S., Harabuchi Y. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Clin Cancer Res 2005, 11:2937-2946.
36. Barbero S., Bonavia R., Bajetto A., Porcile C., Pirani P., Ravetti J.L., et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003, 63:1969-1974.
37. Tan C.T., Chu C.Y., Lu Y.C., Chang C.C., Lin B.R., Wu H.H., et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis 2008, 29:1519-1527.
38. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 2005, 310:117-130.
39. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003, 167:1676-1686.
40. Hwang J.H., Hwang J.H., Chung H.K., Kim D.W., Hwang E.S., Suh J.M., et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003, 88:408-416.
41. Nagle R.B., Hao J., Knox J.D., Dalkin B.L., Clark V., Cress A.E. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 1995, 146:1498-1507.
42. Lee K.Y., Liu Y.H., Ho C.C., Pei R.J., Yeh K.T., Cheng C.C., et al. An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma. J Med 2004, 35:141-149.
43. Kelly K.A., Bardeesy N., Anbazhagan R., Gurumurthy S., Berger J., Alencar H., et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med 2008, 5:e85.
44. Sonnenberg A., Liem R.K. Plakins in development and disease. Exp Cell Res 2007, 313:2189-2203.
45. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 1998, 111(Pt 17):2477-2486.
46. Andra K., Nikolic B., Stocher M., Drenckhahn D., Wiche G. Not just scaffolding: plectin regulates actin dynamics in cultured cells. Genes Dev 1998, 12:3442-3451.
47. Stegh A.H., Herrmann H., Lampel S., Weisenberger D., Andra K., Seper M., et al. Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol 2000, 20:5665-5679.
48. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
49. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350:1945-1952.
50. Bernier J., Cooper J.S., Pajak T.F., van Glabbeke M., Bourhis J., Forastiere A., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27:843-850.